Recce Pharmaceuticals Ltd (RCE.AX)
AUD 0.45
(-3.23%)
AUD 0.45
(-3.23%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -3.39 Million AUD | -174.9% |
| 2023 | -1.31 Million AUD | 88.61% |
| 2022 | -11.5 Million AUD | 44.53% |
| 2021 | -20.74 Million AUD | -698.25% |
| 2020 | -2.59 Million AUD | -878.07% |
| 2019 | 334.02 Thousand AUD | 149.35% |
| 2018 | -676.86 Thousand AUD | 27.15% |
| 2017 | -929.14 Thousand AUD | 74.08% |
| 2016 | -3.58 Million AUD | 26.73% |
| 2015 | -4.89 Million AUD | -5098.74% |
| 2014 | -94.09 Thousand AUD | -119.33% |
| 2013 | -42.9 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | -3.39 Million AUD | 0.0% |
| 2024 FY | -3.39 Million AUD | -159.05% |
| 2024 Q2 | -3.8 Million AUD | 0.0% |
| 2023 Q4 | -1.31 Million AUD | 0.0% |
| 2023 FY | -1.31 Million AUD | 88.61% |
| 2023 Q2 | -1.72 Million AUD | 0.0% |
| 2022 Q2 | -15.69 Million AUD | 0.0% |
| 2022 FY | -11.5 Million AUD | 44.53% |
| 2022 Q4 | -11.5 Million AUD | 0.0% |
| 2021 Q4 | -20.74 Million AUD | 0.0% |
| 2021 FY | -20.74 Million AUD | -698.25% |
| 2021 Q2 | -23.36 Million AUD | 0.0% |
| 2020 Q4 | -2.59 Million AUD | 0.0% |
| 2020 FY | -2.59 Million AUD | -878.07% |
| 2020 Q2 | -4.5 Million AUD | 0.0% |
| 2019 Q2 | 420.71 Thousand AUD | 0.0% |
| 2019 FY | 334.02 Thousand AUD | 149.35% |
| 2019 Q4 | 334.02 Thousand AUD | 0.0% |
| 2018 Q4 | -676.86 Thousand AUD | 0.0% |
| 2018 FY | -676.86 Thousand AUD | 27.15% |
| 2018 Q2 | -1 Million AUD | 0.0% |
| 2017 FY | -929.14 Thousand AUD | 74.08% |
| 2017 Q4 | -929.14 Thousand AUD | 0.0% |
| 2017 Q2 | -2.31 Million AUD | 0.0% |
| 2016 Q4 | -3.58 Million AUD | 0.0% |
| 2016 Q2 | -4.9 Million AUD | 0.0% |
| 2016 FY | -3.58 Million AUD | 26.73% |
| 2015 Q4 | -451.71 Thousand AUD | 0.0% |
| 2015 FY | -4.89 Million AUD | -5098.74% |
| 2015 Q3 | -451.71 Thousand AUD | 0.0% |
| 2014 FY | -94.09 Thousand AUD | -119.33% |
| 2013 FY | -42.9 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | -18.89 Million AUD | 82.03% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -245.801% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 167.02% |
| Biome Australia Limited | -1.56 Million AUD | -117.31% |
| Patrys Limited | -2.24 Million AUD | -51.568% |
| Orthocell Limited | -19.92 Million AUD | 82.955% |
| Imugene Limited | -91.56 Million AUD | 96.291% |
| Noxopharm Limited | -2.31 Million AUD | -46.39% |
| PYC Therapeutics Limited | -65.76 Million AUD | 94.836% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | -11.239% |
| Prescient Therapeutics Limited | -10.16 Million AUD | 66.582% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | 46.296% |
| Cynata Therapeutics Limited | -6.2 Million AUD | 45.271% |
| CSL Limited | 15.76 Billion AUD | 100.022% |
| Arovella Therapeutics Limited | -12.71 Million AUD | 73.289% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -378.627% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 98.144% |
| Starpharma Holdings Limited | -19.83 Million AUD | 82.875% |
| Nanollose Limited | -96.22 Thousand AUD | -3429.368% |
| Memphasys Limited | 4.13 Million AUD | 182.124% |
| Invex Therapeutics Ltd | -6.02 Million AUD | 43.633% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | 31.449% |
| Amplia Therapeutics Limited | -1.82 Million AUD | -86.233% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | 95.718% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -174.234% |
| Race Oncology Limited | -17.18 Million AUD | 80.242% |
| Nyrada Inc. | -4.76 Million AUD | 28.793% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 96.79% |
| Dimerix Limited | -21.99 Million AUD | 84.557% |
| PharmAust Limited | -9.71 Million AUD | 65.039% |
| Immutep Limited | -122.18 Million AUD | 97.221% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 97.512% |
| Alterity Therapeutics Limited | -12.47 Million AUD | 72.787% |
| BTC Health Limited | -2.02 Million AUD | -67.946% |
| Acrux Limited | -1.45 Million AUD | -132.931% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | 80.133% |
| Biotron Limited | -386.06 Thousand AUD | -779.672% |
| Tissue Repair Ltd | -16.44 Million AUD | 79.344% |
| AdAlta Limited | -845.17 Thousand AUD | -301.827% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | 81.717% |
| Hexima Limited | -2.22 Million AUD | -52.552% |
| AnteoTech Limited | -5 Million AUD | 32.098% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | 80.683% |
| Avecho Biotechnology Limited | -5.32 Million AUD | 36.274% |
| Actinogen Medical Limited | -9.13 Million AUD | 62.809% |
| Immuron Limited | -11.48 Million AUD | 70.427% |
| Argenica Therapeutics Limited | -15.91 Million AUD | 78.658% |